Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|December 1, 2020
Cytokine Panels and Pediatric Acute Respiratory Distress Syndrome: A Translational InvestigationDaniel J McKeone, Margaret Mathewson, Priti G Dalal, et al.
Respiratory Research|January 7, 2018
GM-CSF overexpression after influenza a virus infection prevents mortality and moderates M1-like airway monocyte/macrophage polarizationE Scott Halstead, Todd M Umstead, Michael L Davies, et al.
Theranostics|June 7, 2023
Mesenchymal stromal cells and alpha-1 antitrypsin have a strong synergy in modulating inflammation and its resolutionLi Han, Xinran Wu, Ou Wang, et al.
Shock (Augusta, Ga.)|December 20, 2015
Plasma Mitochondrial DNA--a Novel DAMP in Pediatric SepsisValentina Di Caro, Thomas D Walko, R Aaron Bola, et al.
Scientific Reports|August 6, 2017
SH3GLB2/endophilin B2 regulates lung homeostasis and recovery from severe influenza A virus infectionKristin K Fino, Linlin Yang, Patricia Silveyra, et al.
Thorax|October 9, 2023
Identification of molecular subphenotypes in two cohorts of paediatric ARDSNadir Yehya, Matt S Zinter, Jill M Thompson, et al.
Military Medicine|December 2, 2022
Inhaled Sargramostim (Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor) for COVID-19-Associated Acute Hypoxemia: Results of the Phase 2, Randomized, Open-Label Trial (iLeukPulm)Robert Paine, Robert Chasse, E Scott Halstead, et al.
Plos One|May 13, 2015
SP-R210 (Myo18A) Isoforms as Intrinsic Modulators of Macrophage Priming and ActivationLinlin Yang, Marykate Carrillo, Yuchieh M Wu, et al.
The Journal of Clinical Investigation|April 4, 2024
Inflammatory and tissue injury marker dynamics in pediatric acute respiratory distress syndromeNadir Yehya, Thomas J Booth, Gnana D Ardhanari, et al.
Cancer|September 10, 2020
Higher serum PD-L1 level predicts increased overall survival with lapatinib versus trastuzumab in the CCTG MA.31 phase 3 trialPrashanth Moku, Lois Shepherd, Suhail M Ali, et al.
Pageof 5